Home › Stocks › AGIO › All Fund Holders
AGIO — AGIOS PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 46 · Reported value held: $1.15B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 6.46M | $239.58M | 0.00% | Add |
| Farallon Capital Management history | Q2 2026 | 5.92M | $219.59M | 1.02% | Add |
| Vanguard Group history | Q4 2025 | 5.59M | $152.28M | 0.00% | Hold |
| D. E. Shaw & Co history | Q2 2026 | 3.11M | $115.30M | 0.06% | Add |
| Geode Capital Management history | Q2 2026 | 1.57M | $58.43M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 1.15M | $42.71M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 985.83K | $36.58M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 963.26K | $35.75M | 0.00% | Hold |
| Citadel Advisors history | Q2 2026 | 913.19K | $33.89M | 0.00% | Add |
| Arrowstreet Capital history | Q2 2026 | 810.53K | $30.08M | 0.01% | Add |
| AQR Capital Management history | Q2 2026 | 684.34K | $25.40M | 0.01% | Add |
| Northern Trust Corp history | Q2 2026 | 554.71K | $20.59M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 538.13K | $19.97M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 536.38K | $19.91M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 507.87K | $18.85M | 0.00% | Hold |
| Point72 Asset Management history | Q2 2026 | 506.34K | $18.79M | 0.02% | Add |
| Legal & General Investment Management America history | Q2 2026 | 434.72K | $16.13M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 198.69K | $7.37M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 168.15K | $6.24M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 155.17K | $5.76M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 138.80K | $5.15M | 0.00% | Reduce |
| Moore Capital Management history | Q4 2025 | 150.00K | $4.08M | 0.06% | Add |
| Casdin Capital history | Q2 2025 | 100.00K | $3.33M | 0.30% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 62.23K | $2.31M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 53.24K | $1.98M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 39.07K | $1.45M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 37.73K | $1.40M | 0.00% | Reduce |
| Maverick Capital history | Q3 2021 | 26.96K | $1.24M | 0.01% | New |
| Millennium Management history | Q1 2026 | 32.14K | $1.09M | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 23.80K | $804.70K | 0.00% | Hold |
| Wellington Management Group history | Q2 2026 | 20.88K | $774.67K | 0.00% | Reduce |
| CPP Investments history | Q2 2026 | 16.50K | $612.32K | 0.00% | Reduce |
| Balyasny Asset Management history | Q1 2026 | 18.01K | $609.24K | 0.00% | Reduce |
| Prudential Financial history | Q2 2026 | 9.96K | $369.43K | 0.00% | Add |
| Principal Global Investors history | Q2 2024 | 7.59K | $327.45K | 0.00% | Reduce |
| Franklin Resources history | Q1 2026 | 8.29K | $280.35K | 0.00% | New |
| Norges Bank Investment Management history | Q2 2025 | 6.76K | $224.71K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 5.84K | $216.57K | 0.00% | Add |
| Royce & Associates history | Q1 2024 | 7.34K | $214.56K | 0.00% | New |
| MFS Investment Management history | Q4 2021 | 6.12K | $201.00K | 0.00% | Reduce |
| Amundi US history | Q3 2022 | 3.26K | $95.00K | 0.00% | Hold |
| JPMorgan Chase & Co history | Q2 2026 | 300 | $11.41K | 0.00% | New |
| T. Rowe Price Associates history | Q2 2026 | 218.97K | $8.13K | 0.00% | Reduce |
| Baillie Gifford & Co history | Q1 2023 | 186 | $4.27K | 0.00% | Hold |
| Renaissance Technologies history | Q1 2024 | 14.71K | $430 | 0.00% | Reduce |
| Lazard Asset Management history | Q2 2025 | 534 | $17 | 0.00% | Reduce |